A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

Clinical trial NCT04864743 · COMPLETED

Trial details

NCT number: NCT04864743
Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2021-06-22
Primary completion: 2021-10-17
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.